Nothing Special   »   [go: up one dir, main page]

NO962210D0 - Nye piperazin, piperidin og tetrahydropyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye piperazin, piperidin og tetrahydropyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO962210D0
NO962210D0 NO962210A NO962210A NO962210D0 NO 962210 D0 NO962210 D0 NO 962210D0 NO 962210 A NO962210 A NO 962210A NO 962210 A NO962210 A NO 962210A NO 962210 D0 NO962210 D0 NO 962210D0
Authority
NO
Norway
Prior art keywords
piperidine
preparation
pharmaceutical compositions
compositions containing
novel piperazine
Prior art date
Application number
NO962210A
Other languages
English (en)
Other versions
NO314185B1 (no
NO962210L (no
Inventor
Jean-Louis Peglion
Aimee Dessinges
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Alain Gobert
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO962210D0 publication Critical patent/NO962210D0/no
Publication of NO962210L publication Critical patent/NO962210L/no
Publication of NO314185B1 publication Critical patent/NO314185B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19962210A 1995-05-31 1996-05-30 Nye alkoksyarylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO314185B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506436A FR2734819B1 (fr) 1995-05-31 1995-05-31 Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Publications (3)

Publication Number Publication Date
NO962210D0 true NO962210D0 (no) 1996-05-30
NO962210L NO962210L (no) 1996-12-02
NO314185B1 NO314185B1 (no) 2003-02-10

Family

ID=9479526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962210A NO314185B1 (no) 1995-05-31 1996-05-30 Nye alkoksyarylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (16)

Country Link
US (2) US5753662A (no)
EP (1) EP0745598B1 (no)
JP (1) JPH08325257A (no)
CN (1) CN1064356C (no)
AT (1) ATE204574T1 (no)
AU (1) AU705374B2 (no)
CA (1) CA2177774C (no)
DE (1) DE69614608T2 (no)
DK (1) DK0745598T3 (no)
ES (1) ES2162989T3 (no)
FR (1) FR2734819B1 (no)
GR (1) GR3037040T3 (no)
NO (1) NO314185B1 (no)
NZ (1) NZ286698A (no)
PT (1) PT745598E (no)
ZA (1) ZA964485B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
US6436940B2 (en) 1996-12-20 2002-08-20 H. Lundbeck A/S Indane or dihydroindole derivatives
CA2275299C (en) * 1996-12-20 2003-12-16 H. Lundbeck A/S Indane or dihydroindole derivatives
WO1998031679A1 (fr) * 1997-01-21 1998-07-23 Yoshitomi Pharmaceutical Industries, Ltd. Composes de thiophene et leur application medicinale
FR2760014B1 (fr) * 1997-02-27 1999-04-09 Adir Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763589B1 (fr) * 1997-05-22 2001-01-05 Centre Nat Rech Scient Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6040448A (en) 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
WO1999021850A1 (en) * 1997-10-24 1999-05-06 Neurogen Corporation 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands
US6281216B1 (en) 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
KR20010034605A (ko) 1998-03-18 2001-04-25 우에하라 아끼라 방향족 복소환 유도체
CN1166665C (zh) * 1998-03-19 2004-09-15 日本农药株式会社 芳基哌啶衍生物及其用途
EP0953567A3 (en) * 1998-04-29 2003-04-02 Pfizer Products Inc. Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
WO1999064425A1 (en) * 1998-06-09 1999-12-16 Neurogen Corporation Substituted thienocycloalkylpyrazoles: dopamine receptor subtype specific ligands
US6177566B1 (en) * 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
US6806275B2 (en) 2000-09-13 2004-10-19 Nihon Nohyaku Co., Ltd. Arylpiperidine derivatives and use thereof
EP2067775B1 (en) 2001-07-16 2012-04-25 Genzyme Corporation A N-Acylsphingosine glucosyltransferase inhibitor
FR2831166B1 (fr) * 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
US7105513B2 (en) * 2002-08-07 2006-09-12 Sanofi-Avertis Deutschland Gmbh Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
US6960611B2 (en) 2002-09-16 2005-11-01 Institute Of Materia Medica Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2004599B1 (de) * 2006-04-06 2011-11-09 Basf Se Verfahren zur Herstellung eines Nn-Alkyl-Lactams mit verbesserter Farbqualität
CN102224137A (zh) * 2008-11-24 2011-10-19 巴斯夫欧洲公司 制备具有改善颜色质量的n-烷基内酰胺的方法
CN102307854B (zh) 2008-12-04 2014-11-12 巴斯夫欧洲公司 用于制备1，3-和1，4-烷基甲基吡咯烷酮的衣康酸或衣康酸衍生物与伯胺的混合物
WO2010084089A1 (en) 2009-01-22 2010-07-29 Basf Se Mixtures of pvdf, n-alkyllactams and organic carbonate and their applications
US8369001B2 (en) * 2009-07-17 2013-02-05 The United States Of America, As Represented By The Secretary Of The Navy Compact high power terahertz radiation cell
KR102073207B1 (ko) 2009-11-27 2020-02-05 젠자임 코포레이션 글루코실세라마이드 신타아제의 억제제로서 ｇｅｎｚ 112638 헤미타르타르산염의 무정형 및 결정질 형태
CN111560025A (zh) 2009-12-04 2020-08-21 桑诺维恩药品公司 多环化合物及其使用方法
SG10202100751YA (en) 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
EA201990400A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения и композиции и их применение
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CN112135827B (zh) 2018-02-16 2024-01-12 赛诺维信制药公司 盐、晶型及其制备方法
CA3130849A1 (en) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
JP2023523569A (ja) 2020-04-14 2023-06-06 サノビオン ファーマシューティカルズ インク 神経学的および精神障害の治療方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3377347A (en) * 1963-06-14 1968-04-09 Ciba Geigy Corp Cyclobutene derivatives
DE2037852C3 (de) * 1970-07-30 1980-06-26 Boehringer Sohn Ingelheim Neue Piperazinderivate und Verfahren zu ihrer Herstellung
US3859438A (en) * 1971-07-08 1975-01-07 Boehringer Sohn Ingelheim Pharmaceutical compositions containing an n-(1-bicyclic aryl-propyl-2)-n-bicyclic aryl-piperazine and method of use
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE4321366A1 (de) * 1993-06-26 1995-01-05 Merck Patent Gmbh Piperidine und Piperazine

Also Published As

Publication number Publication date
ATE204574T1 (de) 2001-09-15
CA2177774C (fr) 2001-07-24
US5684020A (en) 1997-11-04
EP0745598A1 (fr) 1996-12-04
CN1064356C (zh) 2001-04-11
CA2177774A1 (fr) 1996-12-01
AU705374B2 (en) 1999-05-20
DK0745598T3 (da) 2001-10-08
FR2734819A1 (fr) 1996-12-06
US5753662A (en) 1998-05-19
GR3037040T3 (en) 2002-01-31
CN1142494A (zh) 1997-02-12
EP0745598B1 (fr) 2001-08-22
ZA964485B (en) 1996-12-12
FR2734819B1 (fr) 1997-07-04
AU5455896A (en) 1996-12-12
NO314185B1 (no) 2003-02-10
JPH08325257A (ja) 1996-12-10
DE69614608T2 (de) 2002-07-04
DE69614608D1 (de) 2001-09-27
NO962210L (no) 1996-12-02
PT745598E (pt) 2001-11-30
NZ286698A (en) 1998-02-26
ES2162989T3 (es) 2002-01-16

Similar Documents

Publication Publication Date Title
NO962210D0 (no) Nye piperazin, piperidin og tetrahydropyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HU9700992D0 (en) New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them
AU8680791A (en) Synergistic ultraviolet absorber compositions containing hydroxy aryl triazines and tetraalkyl piperidines
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
IE891379L (en) Benzopyrido piperidine, piperidylidene and piperazine¹compounds
DK0491664T3 (da) Indolderivater som serotonin-antagonister
DE68908040D1 (de) 3-(4-piperidin)-5-(2-sulphonylaminoethyl)-indol-derivate.
DK0867436T3 (da) N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander
FI851931A0 (fi) Nya -karbolin-3-oxadiazolylderivat, foerfarande foer deras framstaellning samt deras anvaendning.
DK0566556T3 (da) 2-substituerede tertiære carbinolderivater af 1,5-iminosukkerarter som antivirale forbindelser
FI912899A (fi) Foerfarande foer framstaellning av hexahydroazepinderivat.
DE69023939D1 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
PT916671E (pt) Novos inibidores de metaloproteases processo para a sua preparacao e as suas composicoes farmaceuticas que os contem
DK0899267T3 (da) Disubstituerede trans-3,4,4a,5,6,10b-hexahydro-2H-napht[1,2-b]-1,4-oxiner, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse
DK0528209T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til D-Vitaminderivater og nye forbindelser
ES2098517T3 (es) Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen.